Design Therapeutics, Inc. (DSGN)
NASDAQ · Healthcare
Design Therapeutics, Inc. Revenue 2020–2025
Design Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Design Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 0.
- Design Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 51000.
- Design Therapeutics, Inc. annual revenue for 2025 was 0.
- Design Therapeutics, Inc. annual revenue for 2024 was 0, a 100.00% decrease from 2020.
- Design Therapeutics, Inc. annual revenue for 2020 was 226000.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Design Therapeutics, Inc. (DSGN) — Frequently Asked Questions
Design Therapeutics, Inc. (DSGN) is a publicly traded US company. It has a market capitalization of $611M. Explore DSGN's stock price, financial statements, earnings history, margins and key ratios below.
What is Design Therapeutics, Inc.'s market cap?
Design Therapeutics, Inc. (DSGN) has a market capitalization of $611M.
What is the DSGN stock price?
DSGN trades at $10.66 (+1.04% on the day).
Is DSGN profitable?
In fiscal 2025, Design Therapeutics, Inc. reported net income of -$70M.